Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X about a recent paper by Jens Hoeppner et al. published in NEJM:
“ESOPEC Pub has landed!
See data review below!
For now, ‘standard’ will appropriately shift to peri-operative FLOT but we should not be satisfied as outcomes remain suboptimal
Ongoing
- does TNT (FLOT + CRT) offer further benefit?
- is it time to consider organ preservation with CRT?
- how to manage those who cannot tolerate FLOT (pre-op CRT seems most appropriate)
Much to unpack amongst our multi-D teams as we consider optimal approach for our patients.”
“Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer”
Authors: Jens Hoeppner, Thomas Brunner, Claudia Schmoor, Peter Grimminger, Florian Lordick et al.
More posts featuring Krishan Jethwa.
